Dermal Photo Allergic Skin Reaction
NCT04070755 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 56
Last updated 2019-08-28
Summary
A 6-Week, Randomized Study to Evaluate the Potential of FMX-101, 4% And Vehicle to Induce a Photo Allergic Skin Reaction in Healthy Volunteers, Using a Controlled Photo Patch Test Design
Conditions
- Healthy
Interventions
- DRUG
-
FMX-101
Sponsors & Collaborators
-
Vyne Therapeutics Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-09-21
- Primary Completion
- 2016-11-18
- Completion
- 2016-12-18
- FDA Drug
- Yes
More Related Trials
-
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
NCT00645164 ·Status: COMPLETED ·Phase: PHASE1
-
Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Lotion) in the Relief of Sunburn Related Symptoms
NCT01085851 ·Status: UNKNOWN ·Phase: PHASE3
-
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
NCT02108483 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of CDX-0159 in Patients With Cold Contact Urticaria, Symptomatic Dermographism, or Cholinergic Urticaria
NCT04548869 ·Status: COMPLETED ·Phase: PHASE1
-
Allergy Skin Patch Artificial Intelligence (AI)
NCT05339750 ·Status: COMPLETED ·Phase: NA
-
Multi-Centre European Photopatch Test Study
NCT00530387 ·Status: COMPLETED ·Phase: NA
-
Drug Challenges Without Prior Skin Testing
NCT03158831 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)
NCT03176342 ·Status: UNKNOWN ·Phase: NA
-
Dermatological Assessment of Photoallergy and Phototoxicity
NCT04250623 ·Status: COMPLETED ·Phase: NA
-
Inter-arm and Inter-period Reproducability of the Dermal Blood Flow Response After a Histamine Skin Prick.
NCT04396977 ·Status: COMPLETED ·Phase: NA
-
Quaternium-15, Use Test
NCT00311454 ·Status: UNKNOWN ·Phase: PHASE4
-
An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea
NCT03352323 ·Status: COMPLETED ·Phase: PHASE3
-
Using Doxepin for Urticaria
NCT05115136 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests
NCT03406117 ·Status: COMPLETED ·Phase: PHASE4
-
18793 - Human Photoallergy Test
NCT02750488 ·Status: COMPLETED ·Phase: NA
-
Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers
NCT03625219 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NCT04882631 ·Status: COMPLETED ·Phase: PHASE1
-
Allergic Disease Onset Prevention Study
NCT05003804 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
NCT00644917 ·Status: COMPLETED ·Phase: PHASE1
-
18850 - Human Photoallergy Test
NCT02751463 ·Status: COMPLETED ·Phase: NA
-
Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Phototoxicity.
NCT04332445 ·Status: COMPLETED ·Phase: NA
-
Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
NCT03015103 ·Status: UNKNOWN ·Phase: NA
-
Penicillin Allergy Testing and Resensitization Rate
NCT03942731 ·Status: COMPLETED
-
18776 - Human Photoallergy Test
NCT02751567 ·Status: WITHDRAWN ·Phase: NA
-
Diagnosing Drug Allergy: the T is the Key
NCT06409884 ·Status: RECRUITING ·Phase: NA